PENTA 4

18

Apr, 1998

Plasma viral load and genotypic resistance patterns in children adding lamivudine to current reverse transcriptase inhibitor therapy (PENTA 4 Trial).

 

Authors:  Kaye S, Loveday C, Gibb DM., Newberry A.

Published in: IVth International Congress Glasgow, 8-12 November 1998. Abstract P305

12

Apr, 1998

A randomised double-blind trial of the addition of lamivudine or matching placebo to current nucleoside analogue reverse transcriptase inhibitor therapy in HIV-infected children: the PENTA-4 trial

 

Author: Aboulker JP, Babiker A, Carrière I, Darbyshire JH Debré M, Giaquinto C, Gibb DM, Harper L, Newberry A, Saidi Y, Tudor-Williams G.

Published in: AIDS 1998; 12 F151-F160.

Read